Hypertension in pregnancy

M D Lindheimer1

  • 1Department of Obstetrics and Gynecology, University of Chicago, Ill.

Insights

Hypertension in pregnancy, particularly preeclampsia-eclampsia, poses significant risks. Recent guidelines recommend specific blood pressure thresholds for treatment and favored medications like hydralazine and methyldopa.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Perinatology

Background:

  • Pregnancy hypertension complicates 10% of pregnancies, causing maternal and fetal morbidity/mortality.
  • Diagnostic challenges and conflicting management strategies exist for hypertensive disorders in gestation.
  • Preeclampsia-eclampsia represents the most severe form of pregnancy-induced hypertension.

Observation:

  • The National High Blood Pressure Education Program's Consensus Report offers updated management recommendations.
  • Key recommendations include adopting the 1972 ACOG classification and using the fifth Korotkoff sound for diastolic pressure.
  • Treatment initiation is advised for diastolic pressures ≥105 mm Hg or ≥100 mm Hg in chronic hypertension near term.

Findings:

  • Parenteral hydralazine and methyldopa are recommended for acute hypertensive crises and chronic hypertension, respectively.
  • Magnesium sulfate remains the standard for eclampsia prevention/treatment, with a call for further efficacy trials.
  • Diuretics are generally contraindicated in preeclampsia but may be continued if pre-conception use or in salt-sensitive chronic hypertension.

Implications:

  • These guidelines aim to standardize and improve the management of hypertensive disorders during pregnancy.
  • Evidence-based recommendations can reduce maternal and fetal complications associated with pregnancy hypertension.
  • Further research, particularly on magnesium sulfate's role, is crucial for refining treatment protocols.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.